Get started
Author

William Miranda

Observed name: Miranda, William
ORCID: 0009-0000-5342-4235
Observed ORCID: 0009-0000-5342-4235
OpenAlex ID: A5134412220
Gastric Cancer Mortality-to-Incidence Ratios in Latin America and the Caribbean: A Machine Learning Analysis of Socioeconomic and Clinical Research Predictors
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al. · JCO Global Oncology · 2
PDF
Abstract 15791: Role of Ventricular Strain in Predicting Ventricular Arrhythmia in Adults with Repaired Tetralogy of Fallot
2026 · Naveenkumar Nallathambi, Ishika Gupta, et al. · Circulation
Abstract 6699: Postoperative Systemic Ventricular Ejection Fraction Decline and Mortality After Reoperative Cardiac Surgery in Adults with Congenital Heart Disease
2026 · Shriganesh Naidu, Elaine Griffeth, et al. · Circulation
TCT-559 Feasibility of Transcatheter Edge-to-Edge Repair in Patients with Complex Adult Congenital Heart Disease
2026 · Smitha Narayana Gowda, Mayra Guerrero, et al. · Journal of the American College of Cardiology
TCT-605 Outcomes of Aortic Stenosis Based on Indexed Aortic Valve Area: Implications in Patients with Large Body Surface Area
2026 · Jwan Naser, Patricia Pellikka, et al. · Journal of the American College of Cardiology
Peripheral oxygen extraction in Fontan - Supplemental Material
2026 · Van Belle, Hannah, Van De Bruaene, Alexander, et al. · Mendeley Data
Supplementary Table S9 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 1 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary FIgure S2 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 3 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S10 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S2 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Data from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 4 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S12 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S7 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S4 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S11 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S1 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S5 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S6 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Figure 2 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S3 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Table S8 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Supplementary Figure S1 from Patient-Level KRAS G12C Prevalence among Hispanic/Latino and Non-Hispanic White Patients in Real-world Clinicogenomic Cohorts
2026 · Daniel F. Pilco-Janeta, Myriam De la Cruz-Puebla, et al.
Works count: 29
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type